Reuters Market Eye - Sun Pharmaceutical Industries falls 1.98 pct after Sept-qtr earnings.
Sun's Q2 profit rose by 15 pct to 15.72 billion rupees.
Profit were in line with estimates despite hopes of a better show after unit Taro Pharmaceutical Industries reported higher earnings earlier - traders.
Taro's quarterly profit grew by 49 pct to a record level of $143 mln.
Profit-taking also seen as the Sun Pharma stock hit a record high of 932.50 rupees earlier this week.
(Reporting by Abhishek Vishnoi)